Macquarie Group LTD Mimedx Group, Inc. Transaction History

Macquarie Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$4.27 - $6.27 $60,493 - $88,827	14,167 New	14,167 $67,000
Q1 2019 May 15, 2019	SELL	$1.84 - $3.74 $13,616 - $27,676	-7,400 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$1.15 - $6.45 $8,510 - $47,730	7,400 New	7,400 $13,000
Q3 2018 Nov 15, 2018	SELL	$3.22 - $6.33 $236,670 - $465,255	-73,500 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.39 - $8.96 $52,822 - $87,808	9,800 Added 15.38%	73,500 $470,000
Q1 2018 May 11, 2018	SELL	$6.69 - $17.96 $16,142 - $43,337	-2,413 Reduced 3.65%	63,700 $444,000
Q4 2017 Feb 15, 2018	SELL	$10.87 - $13.9 $18.3 Million - $23.4 Million	-1,681,996 Reduced 96.22%	66,113 $834,000
Q3 2017 Nov 08, 2017	BUY	$11.86 - $17.34 $20.7 Million - $30.3 Million	1,748,109	1,748,109 $20.8 Million

212

98M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $999M
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.